Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?
about
Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal CancerIntestinal inflammation and the diet: Is food friend or foe?Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.Commonly used fertility drugs, a diet supplement, and stress force AMPK-dependent block of stemness and development in cultured mammalian embryos.The Role of Glucosinolate Hydrolysis Products from Brassica Vegetable Consumption in Inducing Antioxidant Activity and Reducing Cancer Incidence.Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3'-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression.Pharmacokinetics and pharmacodynamics of 3,3'-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes.Two-cell embryos are more sensitive than blastocysts to AMPK-dependent suppression of anabolism and stemness by commonly used fertility drugs, a diet supplement, and stress.
P2860
Q26742065-C7369C67-E2DB-4C61-B375-8D676D998F06Q26765223-6850FFE7-56A9-4976-8B69-2D04FB4AFC10Q34323757-453EFCD4-6949-4169-B787-F3853090B745Q37330730-DF6490E0-445E-4593-A272-7626912EB8CEQ38292317-9E20F96F-A122-4904-80F3-4FECC51F28A1Q41825131-0AAFB2A8-E065-49F7-9CD8-B92F7ED55557Q42371532-54D3F931-8D20-4256-96C6-79D3F0114580Q42479231-EB097C0A-6694-4B80-82CD-8D33A3301C09Q44510337-7F4583F4-1E65-4677-BDAC-1ACD159D34E7
P2860
Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comparative preclinical pharma ...... hemoprevention in the horizon?
@ast
Comparative preclinical pharma ...... hemoprevention in the horizon?
@en
type
label
Comparative preclinical pharma ...... hemoprevention in the horizon?
@ast
Comparative preclinical pharma ...... hemoprevention in the horizon?
@en
prefLabel
Comparative preclinical pharma ...... hemoprevention in the horizon?
@ast
Comparative preclinical pharma ...... hemoprevention in the horizon?
@en
P2093
P2860
P356
P1433
P1476
Comparative preclinical pharma ...... hemoprevention in the horizon?
@en
P2093
Ekaterina Muyzhnek
Igor Kuznetsov
Mikhail Paltsev
Olga Pchelintseva
Vadim Drukh
Vsevolod Kiselev
P2860
P2888
P356
10.1186/1878-5085-4-25
P577
2013-12-10T00:00:00Z
P5875
P6179
1006050683